12 results
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
11 Mar 22
Bio-path Holdings Reports Full Year 2021 Financial Results
7:30am
American Society of Hematology (ASH) Annual Meeting. The poster, titled, “Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
13 Dec 21
Bio-Path Holdings Presents Data from Ongoing Phase 2 Study of Prexigebersen at 2021 American Society of Hematology Annual Meeting
7:40am
and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with High-Risk and Relapsed/Refractory Acute Myeloid
8-K
EX-99.1
8wg9w48q8b62lyknyt
4 Nov 21
Bio-Path Holdings to Present Clinical Data at the 63rd Annual American Society of Hematology Annual Meeting
12:00am
8-K
EX-99.1
akacg36
3 Dec 18
Regulation FD Disclosure
4:29pm
8-K
EX-99.1
6iw4 hwhka4k
2 Nov 18
Bio-Path Holdings to Present Clinical Data at the 60th Annual American Society of Hematology Annual Meeting
4:34pm
8-K
EX-99.1
d0z0wbigb
16 May 18
Bio-path Holdings Reports First Quarter 2018 Financial Results
7:30am
- Prev
- 1
- Next